Ulrika Norin

Image -

Ulrika Norin

go to media item
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
File format:
.jpg
Size:
2715 x 2848, 2.69 MB
Download

Topics

Contacts

Related content

  • Ulrika Norin, CEO Omnio.

    Omnio AB raises 5.5 MSEK in fundraising round

    Omnio AB is developing new drug products based on the pro-inflammatory and immune regulatory effects of the serum protein plasminogen. During fall the company successfully raised 5.5 MSEK in a new share issue and welcomed four new investors to the company. The added investments make it possible for the company to now initiate its planned activities to develop recombinant plasminogen for treatment

Umeå Biotech Incubator Enter your email address to follow Umeå Biotech Incubator

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Umeå Biotech Incubator Check your inbox

Email sent to __email__. Click the link there to follow Umeå Biotech Incubator.

Okay